XML 31 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Earnings Per Share (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Earnings Per Share [Abstract]    
Net Income (Loss) $ (22)us-gaap_IncomeLossFromContinuingOperations $ 200us-gaap_IncomeLossFromContinuingOperations
Weighted Average Number of Shares Outstanding, Basic (in shares) 370,000,000us-gaap_WeightedAverageNumberOfSharesOutstandingBasic [1] 360,000,000us-gaap_WeightedAverageNumberOfSharesOutstandingBasic [1]
Incremental Shares from Assumed Conversion of Dilutive Stock Options, Restricted Stock, and Shares of Common Stock in Rabbi Trust (in shares) 0us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment [2] 5,000,000us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment [2]
Weighted Average Number of Shares Outstanding, Diluted (in shares) 370,000,000us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 365,000,000us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Earnings (Loss) from Continuing Operations Per Share, Basic (in dollars per share) $ (0.06)us-gaap_IncomeLossFromContinuingOperationsPerBasicShare $ 0.56us-gaap_IncomeLossFromContinuingOperationsPerBasicShare
Earnings (Loss) from Continuing Operations Per Share, Diluted (in dollars per share) $ (0.06)us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare $ 0.55us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare
Number of antidilutive stock options, shares of restricted stock and shares of common stock in rabbi trust excluded from calculation above (in shares) 9,000,000us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 6,000,000us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Underwritten public offering (in shares) 24,150,000us-gaap_StockIssuedDuringPeriodSharesOther  
[1] The weighted average number of shares outstanding includes the weighted average shares of common stock issued in connection with the underwritten public offering of 24,150,000 shares of common stock of the Company in first quarter 2015.
[2] (2) For the three months ended March 31, 2015, all outstanding options and non-vested restricted shares have been excluded from the calculation of diluted EPS as the Company incurred a loss for the quarter. Therefore, inclusion of outstanding options and non-vested restricted shares in the calculation of diluted EPS would be anti-dilutive.